This site is intended for healthcare professionals

Lineage enters into exclusive agreement with Neurgain Technologies to evaluate novel delivery system for OPC 1 to treat spinal cord injury.-Neurgain

Read time: 1 mins
Last updated:10th Feb 2021
Published:10th Feb 2021
Condition: Spinal Cord Injury
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest